Healthcare Mergers, Acquisitions & Ventures Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions & Ventures Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiogenesis
American Academy of Ophthalmology Mourns Loss of Judah Folkman, MD, Pioneering Researcher
February 2nd, 2008
The American Academy of Ophthalmology expresses its sadness at the death of Judah Folkman, MD, whose research on angiogenesis inhibitors sparked major advances in the treatment of eye diseases and other illnesses that involve excessive or abnormal angiogenesis, or blood vessel development. "Dr. Folkman's death is a loss to ophthalmology and to all of medicine," said H. Dunbar Hoskins, Jr., MD, executive vice president for the Academy. "Because of his groundbreaking work, we have seen remarkable advances in helping patients with age-related macular degeneration (AMD) save their vision and even regain some of their eyesight." Dr. Folkman was the...
Source: Healthcare Mergers, Acquisitions & Ventures Week (2008-02-02)
|
